166 related articles for article (PubMed ID: 34478828)
1. GPER and IGF-1R mediate the anti-inflammatory effect of genistein against lipopolysaccharide (LPS)-induced nigrostriatal injury in rats.
Du ZR; Gu Y; Xie XM; Zhang M; Jiang GY; Chen WF
J Steroid Biochem Mol Biol; 2021 Nov; 214():105989. PubMed ID: 34478828
[TBL] [Abstract][Full Text] [Related]
2. G protein-coupled estrogen receptor is involved in the anti-inflammatory effects of genistein in microglia.
Du ZR; Feng XQ; Li N; Qu JX; Feng L; Chen L; Chen WF
Phytomedicine; 2018 Apr; 43():11-20. PubMed ID: 29747742
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effect of IGF-1 is mediated by IGF-1R cross talk with GPER in MPTP/MPP
Yuan LJ; Zhang M; Chen S; Chen WF
Mol Cell Endocrinol; 2021 Jan; 519():111053. PubMed ID: 33035625
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid receptor is involved in the neuroprotective effect of ginsenoside Rg1 against inflammation-induced dopaminergic neuronal degeneration in substantia nigra.
Sun XC; Ren XF; Chen L; Gao XQ; Xie JX; Chen WF
J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):94-103. PubMed ID: 26455404
[TBL] [Abstract][Full Text] [Related]
5. G protein-coupled estrogen receptor is involved in the neuroprotective effect of IGF-1 against MPTP/MPP
Yuan LJ; Wang XW; Wang HT; Zhang M; Sun JW; Chen WF
J Steroid Biochem Mol Biol; 2019 Sep; 192():105384. PubMed ID: 31175966
[TBL] [Abstract][Full Text] [Related]
6. Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats.
Chen G; Liu J; Jiang L; Ran X; He D; Li Y; Huang B; Wang W; Fu S
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267220
[TBL] [Abstract][Full Text] [Related]
7. GPER activation is effective in protecting against inflammation-induced nigral dopaminergic loss and motor function impairment.
Mendes-Oliveira J; Lopes Campos F; Videira RA; Baltazar G
Brain Behav Immun; 2017 Aug; 64():296-307. PubMed ID: 28450223
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson's disease models are mediated by GPR109A-dependent mechanisms.
Fu SP; Wang JF; Xue WJ; Liu HM; Liu BR; Zeng YL; Li SN; Huang BX; Lv QK; Wang W; Liu JX
J Neuroinflammation; 2015 Jan; 12():9. PubMed ID: 25595674
[TBL] [Abstract][Full Text] [Related]
9. IGF-1 inhibits MPTP/MPP
Wang XW; Yuan LJ; Yang Y; Zhang M; Chen WF
Am J Physiol Endocrinol Metab; 2020 Oct; 319(4):E734-E743. PubMed ID: 32865008
[TBL] [Abstract][Full Text] [Related]
10. Galectin-1 attenuates neurodegeneration in Parkinson's disease model by modulating microglial MAPK/IκB/NFκB axis through its carbohydrate-recognition domain.
Li Y; Chen N; Wu C; Lu Y; Gao G; Duan C; Yang H; Lu L
Brain Behav Immun; 2020 Jan; 83():214-225. PubMed ID: 31669519
[TBL] [Abstract][Full Text] [Related]
11. Biochanin A Protects Against Lipopolysaccharide-Induced Damage of Dopaminergic Neurons Both In Vivo and In Vitro via Inhibition of Microglial Activation.
Wang J; Wu WY; Huang H; Li WZ; Chen HQ; Yin YY
Neurotox Res; 2016 Oct; 30(3):486-98. PubMed ID: 27417698
[TBL] [Abstract][Full Text] [Related]
12. Distribution and localization patterns of estrogen receptor-beta and insulin-like growth factor-1 receptors in neurons and glial cells of the female rat substantia nigra: localization of ERbeta and IGF-1R in substantia nigra.
Quesada A; Romeo HE; Micevych P
J Comp Neurol; 2007 Jul; 503(1):198-208. PubMed ID: 17480015
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin prevents lipopolysaccharide-induced neurodegeneration in the rat substantia nigra by inhibiting the activation of microglia.
Bai L; Zhang X; Li X; Liu N; Lou F; Ma H; Luo X; Ren Y
Mol Med Rep; 2015 Jul; 12(1):1002-8. PubMed ID: 25777539
[TBL] [Abstract][Full Text] [Related]
14. Vanillin Protects Dopaminergic Neurons against Inflammation-Mediated Cell Death by Inhibiting ERK1/2, P38 and the NF-κB Signaling Pathway.
Yan X; Liu DF; Zhang XY; Liu D; Xu SY; Chen GX; Huang BX; Ren WZ; Wang W; Fu SP; Liu JX
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208679
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rg1 Exerts Anti-inflammatory Effects via G Protein-Coupled Estrogen Receptor in Lipopolysaccharide-Induced Microglia Activation.
Gao XQ; Du ZR; Yuan LJ; Zhang WD; Chen L; Teng JJ; Wong MS; Xie JX; Chen WF
Front Neurosci; 2019; 13():1168. PubMed ID: 31787867
[TBL] [Abstract][Full Text] [Related]
16. Modulation of M1/M2 polarization by capsaicin contributes to the survival of dopaminergic neurons in the lipopolysaccharide-lesioned substantia nigra in vivo.
Bok E; Chung YC; Kim KS; Baik HH; Shin WH; Jin BK
Exp Mol Med; 2018 Jul; 50(7):1-14. PubMed ID: 29968707
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside Rb1 protects dopaminergic neurons from inflammatory injury induced by intranigral lipopolysaccharide injection.
Li DW; Zhou FZ; Sun XC; Li SC; Yang JB; Sun HH; Wang AH
Neural Regen Res; 2019 Oct; 14(10):1814-1822. PubMed ID: 31169200
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory effects of genistein via suppression of the toll-like receptor 4-mediated signaling pathway in lipopolysaccharide-stimulated BV2 microglia.
Jeong JW; Lee HH; Han MH; Kim GY; Kim WJ; Choi YH
Chem Biol Interact; 2014 Apr; 212():30-9. PubMed ID: 24491678
[TBL] [Abstract][Full Text] [Related]
19. Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson's disease by suppressing the activation of the AKT and NF-κB signaling pathways.
Li Y; Zeng Y; Meng T; Gao X; Huang B; He D; Ran X; Du J; Zhang Y; Fu S; Hu G
Int Immunopharmacol; 2019 Oct; 75():105739. PubMed ID: 31351366
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
